Background This study examined the outcomes of patients holding or continuing clopidogrel
during the preoperative period. Methods We reviewed all patients taking clopidogrel who …

Objective: Effective antiplatelet therapy may decrease the risk of complications following off-
pump coronary artery bypass surgery (CABG). We prospectively evaluated the safety and …

Objectives: The objective of this study was to examine the clinical efficacy of clopidogrel
treatment on death and recurrent myocardial infarction (MI) among MI patients …

BACKGROUND: Short-term use of clopidogrel plus aspirin among patients with acute
coronary syndrome reduces ischemic events, but concerns about coronary artery bypass …

Background Clopidogrel has become standard treatment after urgent percutaneous
coronary revascularization. Due to its enhanced and irreversible platelet inhibition, patients …

Objectives The aim of the present study was to define the feasibility and clinical impact of
complying with national consensus recommendations on perioperative management of …

Objective: The optimal timing for discontinuation of clopidogrel before surgery remains
under debate. The purpose of this study is to determine the effect of preoperative clopidogrel …

The aim of this study was to evaluate the effects of clopidogrel on blood loss and blood and
blood products usage following CABG. One hundred and ninety-six patients underwent …

Aspirin and clopidogrel together reduce the risk of recurrent thrombosis-related events in
patients with acute coronary syndromes or stent revascularization and may reduce …

Background—Clopidogrel inhibits intimal hyperplasia in animal studies and therefore may
reduce saphenous vein graft (SVG) intimal hyperplasia after coronary artery bypass grafting …